Business
Cannabis Consortium Partners With a Group That Will Own a Dispensary in Downtown Los Angeles, CA
Cannabis Consortium Partners With a Group That Will Own a Dispensary in Downtown Los Angeles, CA.
About this update from Aj1g Inc.
[{"type":"text","content":"\n\n COCONUT CREEK, Fla., March 02, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Bahamas Development Corporation (OTC:BDCI) subsidiary company Cannabis Consortium, Inc., has partnered with a group that will own a percentage of a Pre-ICO marijuana dispensary.\n The dispensary currently operates in an under 1,000 square foot, and is relocating to an 8,000 square foot, facility. The new dispensary has current licenses for Retail, Manufacturing, and Cultivation. There are approximately 160 Pre-ICO licenses in the Los Angeles area and new applications will not be available for about 18 months. Pre-ICO refers to medical marijuana dispensaries that were open before September 14, 2007, when the Medical Marijuana Interim Control Ordinance (ICO) went into effect. The ICO is a city ordinance that prohibited new dispensaries from opening and only allowed Los Angeles dispensaries already in existence to remain open, provided they registered with the City Clerks' Office prior to Nov. 13 of the same year. The Manufacturing license that comes with the new dispensary is required to produce oil, edibles and concentrates. The Manufacturing license is vital for Cannabis Consortium to produce and sell its own branded patented products throughout California. The group Cannabis Consortium has multiple years of operational experience in the MJ sector and access to deals that are not publicly advertised. The initial company Cannabis was going to partner with to sell its products through is the lead partner in this group. The group is investigating the potential of several operating dispensaries in order to purchase percentages that can range up to 50% ownership. About Cannabis Consortium: Cannabis Consortium is actively pursuing five (5) revenue streams in the cannabis marketplace: Specialty itemsFoodstuffs/EdiblesBeveragesInvestmentResearch/New Products The first three (3) revenue streams are comprised of edible products and ancillary items related to the edible marketplace. The 4th stream Invests into other private cannabis operations. The final stream, research, will focus on the medical benefits of CBD oils for the treatment of animals. Trans Global Group, Inc. is the majority shareholder of BDCI and has an exclusive marketing agreement with Cannabis Consortium for its specialty products. Bahamas Development Corporation, in compliance with SEC r...